Beaver, any idea how to stop this illegal game? I filled out the SEC complaint form several times in the past as and when I suspected this, even hinting @ Wall Street media for misleading, and it never apparently worked!! If we can't stop it, how do we deal with it as investors? We have no choice but to be just the monkeys to follow the market!!
Rattle bug, you took the words out of my mouth!! Political corruption and cheating are a hallmark of greed in people as long as money is the most sought after commodity of our society. Only the cunning and crooks can prosper!
Rusty, I have lost my respect for Scarlett, and also for Huh, both of who I find too cozy to WS jerks than to sincere shareholders. I consider both to be real bozos.
Meliorist, I do not believe that SEC is without any tools, although I do agree that our Current-day Congress seems to have forgotten that they are there to work for us, the people, and not vested interests. Perhaps this is an outcome of our money-driven system that has deeply influenced our mind and not just that of politicians. After all, our politicians are nothing but our society's reflection!
Black, this is a board where you will not be able to get any specific answer to your questions! However, I do believe that the FDA must have that issue in their mind because, for a breakthrough drug which may have potentially large international demand, manufacturing, distribution, and economic-cost production capability should be important. It's not just what Mayo finds that is important for such a product that is going to be a commercial product, it's those issues too that may be central to final licensing. Involvement of a large pharma, having international marketing and distribution capability IS a necessity for a BTD like IMET; but the two bozos don't want to give at least some idea about it to us shareholders. Perhaps, they are already discussing those aspects to their WS buddies!!
Oh, I know that my views are not liked by posters and visitors of this board; but, for certain important issues like this raised by a poster like you I do want to respond.
Another thing you can do is place a sell order for a high limit good for 60 days! Then, your broker can't borrow it for his use.
If you're a wise beaver, you will use strong and long sticks that are hard to steal and your dam won,t break!,
Please use your common sense. This year the worms started the game early, instead of usual October and have to end early! This year monkey shorts tried to beat institutional worms. The govt has to find a drug to effectively kill these worms. Until then, the worms will keep multiplying and crowd up. There are a lot of those visiting this board too!!
If big pharmas are connected to hedge funds which keep shorting shares of small biotechs whose products may threaten their market for the pharmas' products and, thereby, continually disrupt funding plans for the biotechs? I will not be!!
Black, you are persistently after the management on one hand while, on the other hand, End is perpetually optimistic so much so that his statements since July of Hold coming off soon have become a joke. I am just looking for all probable reasons for the persistent decline of share price and downgrading by WS handlers. To-day's drop may be partly the domino effect. But, if you compare Geron's share-price movement to-day versus that of other biotechs in similar situation, it is disgusting. There appears to be a deliberate attempt at bringing the SP down to below $2.00 and leave it there at the close whereas SP of others came up. If Geron has a BT product, and Mayo is backing it, this contempt by the WS betters is something to worry about. Sure, the management is inept but the product is a golden nugget. So....what is going on? Can anybody say with confidence that the company can do well by itself and with this management?
Those who put a lot of faith in Scarlett and Huh forget that Scarlett gets compensated well and so did Huh and they do not need SP doing well. Of course, when time comes to look for more funding, they may manage to find a partner or an acquirer like they did for the stem- cell assets at throw away price and get lucrative deal for themselves. Can any retail shareholder or even a minority institutional holder stop them doing so? If you are sure it can be done, why didn't any one stop them for the lousy stem-cell deal?! Also, do not forget that a low SP can't get more undoing than a sustained high SP!! It's thus necessary to take solid steps before such a need arises to stabilize SP to a comfortably high SP. A lot of pundits posting on this board can't grasp this simple fact!! This is one reason why I call both "the bozos".
If the news w.r.t. the MF trial as discussed under this post is true, it must have been known underhand to those WS crooks who traded down the SP today! Does it mean we lost a great opportunity to add more because it now will gap up pretty high tomorrow and I will have to be sorry to come to a conclusion that the Geron management is not shareholder-friendly?!
Scarlett is a physician, and so is Huh who also worked at Sloan-Kettering, and they both squeezed millions in salary and compensation from the financially strapped small company, getting much more than Tefferi!! How could they screw up, and not Tefferi? Vette, these two bozos must be held accountable for the FDA slap, and none else. Excuses do not make a credible answer. We all know by now that the fate of Geron's multi-center Ph 2 MF trial is solely dependent on Tefferi's work and not what Geron's inhouse work which they screwed up! Aren't we all, therefore,anxiously waiting for the disclosure at ASH?
that's what really may be Geron's problem. Takeover by a large pharma appears to be the only solution. Until then, it needs good, credible and non-greedy managers.